New combo therapy shows promise for Tough-to-Treat head and neck cancer
NCT ID NCT03082534
First seen Jan 29, 2026 · Last updated May 17, 2026 · Updated 11 times
Summary
This study tested a combination of two drugs, pembrolizumab and cetuximab, in 78 people with advanced head and neck cancer that had come back or spread. Participants were grouped based on whether they had tried these drugs before. The goal was to see if the combination could shrink tumors or slow the disease. This is not a cure, but aims to help control the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCSD Moores Cancer Center
La Jolla, California, 92093, United States
-
University of California Los Angeles Cancer Center
Los Angeles, California, 90095, United States
-
University of Michigan Cancer Center
Ann Arbor, Michigan, 48109, United States
-
Washington School of Medicine Cancer Center
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.